Elafibranor
- Part D specialty tier in 81% of formularies (2026Q3)
- IQIRVO
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Elafibranor: storage and handling
- Freezing
- Not addressed
- Room temperature
- at or below 30°C (86°F)
Label statement
Store at room temperature 15°C to 30°C (59°F to 86° F).
- Back into the refrigerator
- Not addressed
- Light
- Not addressed
- Shaking
- Not addressed
All storage statements on the label (2)
- Store at room temperature 15°C to 30°C (59°F to 86° F).
- Store in the original package (bottle and carton) to protect from moisture and light.
FDA label version 4, effective August 11, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.